Author: Carly Behm

Becker's has reported on four studies since Aug. 23 that spine and orthopedic surgeons should know.

Private equity investments have grown in the spine and orthopedic space, with many physicians taking advantage of the opportunities it offers. However, there are also concerns among experts about the long-term viability of taking outside capital.

It's not uncommon for some orthopedic surgeries to be done in the outpatient setting, but many factors go into creating a successful program.

Stryker's latest device launch and four more updates from spine and orthopedic medtech companies since Sept. 1:

Pacira BioSciences' Exparel drug was found to be effective in treating pain after total knee replacements, according to a study.

SeaSpine's WaveForm TA system was released in a full commercial launch, the devicemaker said Sept. 6.

Myrtle Beach, S.C.-based OrthoSC opened a location in the space of a former restaurant, The Post and Courier reported Sept. 6.

Jason Tinley, MD, completed the first commercial case with Centinel Spine's Prodisc C Vivo, the devicemaker said Sept. 7.

A study published in the July 2022 edition of Operative Neurosurgery supports the long-term use of Premia Spine's Tops spinal joint replacement system.

Ortho Regenerative Technologies is now called ChitogenX, the company said Sept. 7.